End-of-life decisions and off-label drug use
Virtual Mentor
.
2013 Aug 1;15(8):649-52.
doi: 10.1001/virtualmentor.2013.15.8.ecas3-1308.
Authors
Laura L Tenner
1
,
Paul R Helft
Affiliation
1
Third year of a hematology/oncology fellowship at Indiana University School of Medicine in Indianapolis. She graduated from a clinical ethics fellowship program at the Charles Warren Fairbanks Center for Medical Ethics.
PMID:
23937778
DOI:
10.1001/virtualmentor.2013.15.8.ecas3-1308
No abstract available
MeSH terms
Decision Making*
Drug Labeling*
Ethics, Medical
Humans
Neoplasms / drug therapy*
Off-Label Use / ethics*
Physician-Patient Relations / ethics*
Terminal Care / ethics*